Search - tctmd.com

Displaying 101 - 120 of 164

Sort: Relevancy | Date

Presentation TCT 2014

Interatrial Septum Stenting in Idiopathic Pulmonary Hypertension

Presenter: Bagrat Alekyan

September 13, 2014

Presentation TVT 2014

Impact of Pulmonary Hypertension, RV Dysfunction, and/or Severe Tricuspid Regurgitation on Mitral Valve Therapies

Presenter: E. Murat Tuzcu

June 05, 2014

News Conference News EuroPCR 2014

Early Data Show Novel Catheter-Implanted Device Benefits Patients with Left Heart Failure

Caitlin E. Cox

May 22, 2014

News Daily News

FRANCE 2 Registry Yields Early Mortality Risk Score for TAVR

April 24, 2014

News Daily News

New Valvular Heart Disease Guidelines Integrate Catheter-based Interventions

L.A. McKeown

March 20, 2014

News Daily News

Patients with Severe Pulmonary Hypertension Benefit from TAVR Despite Increased Mortality

L.A. McKeown

March 13, 2014

News Daily News

Los Pacientes con Hipertensión Pulmonar Severa se Benefician de la TAVR a pesar de una Mayor Mortalidad

L.A. McKeown

March 13, 2014

Presentation

Prognostic Implications of Pulmonary Hypertension in Pts with Severe Aortic Stenosis Undergoing TAVR

Presenter: Adrien Lu?on

March 06, 2014

News Daily News

Ultrasound-Accelerated Thrombolysis More Effective Than Heparin Alone for Intermediate PE

January 01, 2014

News Conference News AHA 2013

AHA 2013: Mix of Positive, Negative Trials Help Guide Interventional Practice

November 24, 2013

News Conference News TCT 2013

Pulmonary Artery Denervation Procedure May Improve Hemodynamic Outcomes in PAH

November 05, 2013

Presentation TCT 2013

Pulmonary artery denervation to treat pulmonary arterial hypertension: a single-center, prospective, first-in-man PADN-1 study

Presenter: Shao-?Liang Chen

October 29, 2013

Presentation TCT 2013

Efficacy and Safety of Balloon Pulmonary Angioplasty for Non-operable Chronic Thromboembolic Pulmonary Hypertension in Comparison to Pulmonary Endarterectomy for Operable Patients

Presenter: Yu Taniguchi

October 29, 2013

Presentation TCT 2013

When Does Pulmonary Hypertension, RV Dysfunction and/or Tricuspid Regurgitation Derail the Potential for Successful Mitral Valve Intervention?

Presenter: Michael Davidson

October 28, 2013

Presentation TCT 2013

Radiofrequency Pulmonary Artery Denervation for Pulmonary Hypertension: Hemodynamic Results and Pathologic Insights from a Porcine Model

Presenter: Alex Rothman

October 28, 2013

Presentation TCT 2013

Pulmonary Artery Denervation for Pulmonary Hypertension: PADN-1 Results and Fuure Clinical Studies

Presenter: Shao Liang Chen

October 28, 2013

Presentation TCT 2013

ASD and Pulmonary Hypertension: Implications for Closure

Presenter: Robert Sommer

October 27, 2013

News Daily News

TAVR Patients with Moderate/Severe Mitral Regurgitation Carry Worse Prognosis

October 11, 2013

News Daily News

Effect of PCI-Related Bleeding on Mortality Risk Varies by Location

Caitlin E. Cox

August 05, 2013

News Daily News

Pulmonary Denervation Shows Promise for Resistant Pulmonary Hypertension

Yael L. Maxwell

July 19, 2013

Advertisement

Interatrial Septum Stenting in Idiopathic Pulmonary Hypertension

Impact of Pulmonary Hypertension, RV Dysfunction, and/or Severe Tricuspid Regurgitation on Mitral Valve Therapies

Early Data Show Novel Catheter-Implanted Device Benefits Patients with Left Heart Failure

FRANCE 2 Registry Yields Early Mortality Risk Score for TAVR

New Valvular Heart Disease Guidelines Integrate Catheter-based Interventions

Patients with Severe Pulmonary Hypertension Benefit from TAVR Despite Increased Mortality

Los Pacientes con Hipertensión Pulmonar Severa se Benefician de la TAVR a pesar de una Mayor Mortalidad

Prognostic Implications of Pulmonary Hypertension in Pts with Severe Aortic Stenosis Undergoing TAVR

Ultrasound-Accelerated Thrombolysis More Effective Than Heparin Alone for Intermediate PE

AHA 2013: Mix of Positive, Negative Trials Help Guide Interventional Practice

Pulmonary Artery Denervation Procedure May Improve Hemodynamic Outcomes in PAH

Pulmonary artery denervation to treat pulmonary arterial hypertension: a single-center, prospective, first-in-man PADN-1 study

Efficacy and Safety of Balloon Pulmonary Angioplasty for Non-operable Chronic Thromboembolic Pulmonary Hypertension in Comparison to Pulmonary Endarterectomy for Operable Patients

When Does Pulmonary Hypertension, RV Dysfunction and/or Tricuspid Regurgitation Derail the Potential for Successful Mitral Valve Intervention?

Radiofrequency Pulmonary Artery Denervation for Pulmonary Hypertension: Hemodynamic Results and Pathologic Insights from a Porcine Model

Pulmonary Artery Denervation for Pulmonary Hypertension: PADN-1 Results and Fuure Clinical Studies

ASD and Pulmonary Hypertension: Implications for Closure

TAVR Patients with Moderate/Severe Mitral Regurgitation Carry Worse Prognosis

Effect of PCI-Related Bleeding on Mortality Risk Varies by Location

Pulmonary Denervation Shows Promise for Resistant Pulmonary Hypertension

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content